🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Saxagliptin + Metformin XR

Found 18 matching trials

Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc

PHASE1

Study in healthy subjects to measure amount of drug in blood after dosing w...

Status

Completed

Location

Research Site

Start Date

2011-10

Trial ID

NCT01441869

Treatments Being Tested

Onglyza (saxagliptin)Diabex 5-mg saxagliptin/1000 mg metformin Diabex 5-mg saxagliptin/500 mg metformin

A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration

PHASE1

The primary objective of this study is to assess the pharmacokinetic parame...

Status

Completed

Location

Research Site

Start Date

2013-02

Trial ID

NCT01755494

Treatments Being Tested

Saxagliptin 5 mg Metformin XR 500 mg Mertformin XR 2 x 500 mg Komboglyze XR 5/500 mg Komboglyze XR 5/1000 mg

Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)

PHASE1

The purpose of this study is to demonstrate bioequivalence (BE) of a 5 mg s...

Status

Completed

Location

Ppd Development, Lp

Start Date

2009-11

Trial ID

NCT01192139

Treatments Being Tested

saxagliptin metformin XR saxagliptin + metformin XR (FDC tablet)

Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM

PHASE1

The purpose of this study is to evaluate the pharmacokinetics of Saxaglipti...

Status

Terminated

Location

Osborne Research Center

Start Date

2012-09

Trial ID

NCT01525225

Treatments Being Tested

Metformin immediate release (IR)Saxagliptin Metformin IR Saxagliptin/Metformin XR FDC Metformin XR

Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR

PHASE1

The purpose of this study is to demonstrate bioequivalence (BE) of a 5 mg s...

Status

Completed

Location

PPD Development, LP

Start Date

2009-11

Trial ID

NCT01192152

Treatments Being Tested

saxagliptin Glucophage XR saxagliptin + metformin XR (FDC tablet)

Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia

PHASE4

Saxagliptin + Metformin XR (S+M) will be effective in stabilizing blood glu...

Status

Completed

Location

John Stroger Hospital of Cook County

Start Date

2014-09-09

Trial ID

NCT01267448

Treatments Being Tested

Glipizide XL Saxagliptin + Metformin XR Metformin XR

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

PHASE3

To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118)...

Status

Completed

Location

Research Site

Start Date

2012-05

Trial ID

NCT01434186

Treatments Being Tested

Placebo matching with Saxagliptin Metformin IR Metformin XR Saxagliptin

A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

PHASE1

A Study to Assess the Fed-state Bioequivalence of a Triple Fixed-Combinatio...

Status

Completed

Location

Research Site

Start Date

2017-05-29

Trial ID

NCT03169959

Treatments Being Tested

2.5 mg Saxagliptin tablet 5 mg dapagliflozin / 1000 mg metformin XR tablet Triple FCDP - 2.5 mg saxagliptin / 5 mg dapagliflozin / 1000 mg metformin XR 5 mg saxagliptin 10 mg dapagliflozin / 1000 mg metformin XR tablet Triple FCDP - 5 mg saxagliptin / 10 mg dapagliflozin / 1000 mg metformin XR

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

PHASE3

The purpose of this study is to learn if a combination of BMS-477118 (Saxag...

Status

Completed

Location

Central Alabama Research

Start Date

2012-07

Trial ID

NCT01606007

Treatments Being Tested

Saxagliptin Metformin XR Dapagliflozin Placebo matching with Dapagliflozin Placebo matching with Saxagliptin

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

PHASE3

This protocol will compare 24 hour glucose control for subject taking saxag...

Status

Completed

Location

Dedicated Phase I, Inc.

Start Date

2008-07

Trial ID

NCT00683657

Treatments Being Tested

Saxagliptin Placebo

Previous Next